ResMed | RMD - Stock



ResMed reported $927.71M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Ansell USD 457.9M 32.1M Jun/2024
AtriCure USD 76.34M 1.43M Jun/2025
Baxter International USD 2.17B 124M Mar/2025
Cochlear AUD 391.6M 70.1M Jun/2024
Cooper Companies USD 881M 700K Jul/2025
CSL USD 6.14B 175M Dec/2024
Dexcom USD 570.7M 32.5M Jun/2025
Edwards Lifesciences USD 1.11B 27.2M Mar/2025
Fisher Paykel Healthcare NZD 342.9M 22.5M Mar/2025
Globus Medical USD 772.13M 108.53M Jun/2025
Haemonetics USD 360.53M 4.61M Jun/2025
Hologic USD 713.7M 3M Jun/2025
Idexx Laboratories USD 392.58M 3.41M Jun/2025
Insulet USD 446.9M 6.1M Jun/2025
Integra LifeSciences USD 465.13M 19.71M Jun/2025
Intuitive Surgical USD 1.67B 113.4M Jun/2025
Masimo USD 318.5M 17.3M Jun/2025
Medtronic USD 5.48B 134M Apr/2025
Philips EUR 3.23B 99M Jun/2025
Ramsay Health Care AUD 379.4M 4.5M Jun/2024
ResMed USD 927.71M 65.07M Jun/2025
Sigma Healthcare AUD 324.85M 25.65M Jan/2023
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Steris USD 641.2M 59.87M Jun/2025
Teleflex USD 693.69M 49.71M Jun/2025
Thermo Fisher Scientific USD 5.56B 335M Jun/2025